| 1(R),2(S)-epoxy Cannabidiol |
|
|
|
|
|
|
|
| 15-Oxospiramilactone |
|
|
|
|
|
|
98.96% |
| 16,16-Dimethyl prostaglandin E2 |
|
|
|
|
|
|
99.02% |
| 2,5-Dimethylcelecoxib |
|
|
|
|
|
|
99.57% |
| 2,5-Hexanedione-d10 |
|
|
|
|
|
|
99.43% |
| 2-Hydroxyanthraquinone |
|
|
|
|
|
|
98.0% |
| 2-Hydroxycinnamaldehyde |
|
|
|
|
|
|
99.86% |
| 21H7 |
|
|
|
|
|
|
|
| 3289-8625 |
|
|
|
|
|
|
99.19% |
| 4,4'-Di-O-methylellagic acid |
|
|
|
|
|
|
|
| 4,5-Dihydronaphtho[1,2-b]thiophene-2-carboxylic acid |
|
|
|
|
|
|
|
| 5T4_0108 |
|
|
|
|
|
|
|
| 8BTC |
|
|
|
|
|
|
|
| 9-Hydroxycanthin-6-one |
|
|
|
|
|
|
|
| A3334 |
|
|
|
|
|
|
99.64% |
| AACA |
|
|
|
|
|
|
99.39% |
| ABC99 |
|
|
|
|
|
|
98.48% |
| Adavivint |
|
|
|
|
|
|
98.85% |
| AMG-167 |
|
|
|
|
|
|
|
| Anti-5T4 scFv-Fc Antibody |
|
|
|
|
|
|
|
| Anti-APCDD1 Antibody |
|
|
|
|
|
|
|
| Anti-DKK2 Antibody |
|
|
|
|
|
|
|
| Anti-FZD5 Antibody |
|
|
|
|
|
|
|
| Anti-Kremen2 Antibody |
|
|
|
|
|
|
|
| Anti-LGR5/GPR49 Antibody (18G7H6A3) |
|
|
|
|
|
|
98.64% |
| Anti-LRP5 Antibody |
|
|
|
|
|
|
|
| Anti-LRP6 Antibody |
|
|
|
|
|
|
|
| Anti-Mouse DKK3 Antibody (DKK3-4.22) |
|
|
|
|
|
|
95.00% |
| Anti-RSPO1 Antibody |
|
|
|
|
|
|
96.18% |
| Anti-RSPO2 Antibody |
|
|
|
|
|
|
|
| Anti-TEM8 Antibody |
|
|
|
|
|
|
|
| Anti-TPBG Antibody |
|
|
|
|
|
|
96.81% |
| Antiproliferative agent-76 |
|
|
|
|
|
|
|
| Antitumor agent-174 |
|
|
|
|
|
|
|
| APHS |
|
|
|
|
|
|
99.0% |
| Apoptosis inducer 22 |
|
|
|
|
|
|
|
| ARUK3001185 |
|
|
|
|
|
|
99.28% |
| AS1134900 |
|
|
|
|
|
|
98.87% |
| aStAx-35R |
|
|
|
|
|
|
|
| aStAx-35R TFA |
|
|
|
|
|
|
99.07% |
| Astragaloside I |
|
|
|
|
|
|
99.81% |
| AV023 |
|
|
|
|
|
|
99.31% |
| AXIN2/β-catenin-IN-1 |
|
|
|
|
|
|
|
| AZ1366 |
|
|
|
|
|
|
|
| BChE-IN-49 |
|
|
|
|
|
|
|
| BIBO3304 diTFA |
|
|
|
|
|
|
|
| BIM-46174 |
|
|
|
|
|
|
|
| BMD4503-1 |
|
|
|
|
|
|
|
| BMD4503-2 |
|
|
|
|
|
|
99.21% |
| BML-284 |
|
|
|
|
|
|
99.99% |
| BML-284 hydrochloride |
|
|
|
|
|
|
|
| Box5 |
|
|
|
|
|
|
98.81% |
| Box5 TFA |
|
|
|
|
|
|
99.50% |
| Butrin |
|
|
|
|
|
|
|
| C-82 |
|
|
|
|
|
|
99.91% |
| C1s Enzyme |
|
|
|
|
|
|
|
| Carboxylesterase-IN-2 |
|
|
|
|
|
|
99.91% |
| Carboxylesterase-IN-3 |
|
|
|
|
|
|
98.27% |
| Cardiogenol C |
|
|
|
|
|
|
|
| Cardiogenol C hydrochloride |
|
|
|
|
|
|
99.79% |
| Cardionogen 1 |
|
|
|
|
|
|
99.21% |
| Cardionogen-2 |
|
|
|
|
|
|
|
| CCT031374 hydrobromide |
|
|
|
|
|
|
98.08% |
| CCT036477 |
|
|
|
|
|
|
99.42% |
| CCT070535 |
|
|
|
|
|
|
|
| CCT251545 |
|
|
|
|
|
|
99.39% |
| CDK8-IN-11 |
|
|
|
|
|
|
98.18% |
| CDK8-IN-11 hydrochloride |
|
|
|
|
|
|
|
| CDK8-IN-16 |
|
|
|
|
|
|
|
| CDK8-IN-2 |
|
|
|
|
|
|
|
| CDK8-IN-20 |
|
|
|
|
|
|
|
| CGK012 |
|
|
|
|
|
|
99.96% |
| CK2-IN-9 |
|
|
|
|
|
|
|
| Combretastatin A-1 phosphate tetrasodium |
|
|
|
|
|
|
|
| Coronaridine |
|
|
|
|
|
|
99.23% |
| CPA inhibitor |
|
|
|
|
|
|
99.78% |
| CWP232228 |
|
|
|
|
|
|
98.09% |
| cycFWRPW |
|
|
|
|
|
|
|
| Dalbinol |
|
|
|
|
|
|
|
| Dalosirvat |
|
|
|
|
|
|
98.22% |
| Desmethylicaritin |
|
|
|
|
|
|
99.77% |
| DHC-156 |
|
|
|
|
|
|
99.54% |
| DIF-3 |
|
|
|
|
|
|
99.84% |
| DJ-1-IN-1 |
|
|
|
|
|
|
98.60% |
| DK419 |
|
|
|
|
|
|
99.86% |
| E09241 |
|
|
|
|
|
|
|
| E722-2648 |
|
|
|
|
|
|
|
| E722-2648 TFA |
|
|
|
|
|
|
96.33% |
| Elaidic acid-d17 |
|
|
|
|
|
|
|
| Elaidic acid-d9 |
|
|
|
|
|
|
99.0% |
| EML631 |
|
|
|
|
|
|
|
| EMT inhibitor-1 |
|
|
|
|
|
|
99.82% |
| ETC-159 |
|
|
|
|
|
|
99.13% |
| Evabosmig |
|
|
|
|
|
|
|
| exo-IWR-1 |
|
|
|
|
|
|
98.75% |
| EXQ-2d |
|
|
|
|
|
|
|
| F7H |
|
|
|
|
|
|
99.95% |
| FH535 |
|
|
|
|
|
|
99.95% |
| FIDAS-3 |
|
|
|
|
|
|
99.40% |
| FJ9 |
|
|
|
|
|
|
|
| Fluc-IN-1 |
|
|
|
|
|
|
98.44% |
| Foscenvivint |
|
|
|
|
|
|
99.56% |
| Foxy-5 |
|
|
|
|
|
|
99.02% |
| Foxy-5 TFA |
|
|
|
|
|
|
99.17% |
| fStAx-35R TFA |
|
|
|
|
|
|
97.35% |
| Fz7-21 |
|
|
|
|
|
|
99.31% |
| Fz7-21 TFA |
|
|
|
|
|
|
98.12% |
| Fz7-21S |
|
|
|
|
|
|
98.91% |
| FZD7 antagonist 1 |
|
|
|
|
|
|
|
| FzM1 |
|
|
|
|
|
|
98.72% |
| FzM1.8 |
|
|
|
|
|
|
98.93% |
| G-631 |
|
|
|
|
|
|
99.88% |
| G244-LM |
|
|
|
|
|
|
98.32% |
| Gallocyanine chloride |
|
|
|
|
|
|
92.00% |
| Getacatetide |
|
|
|
|
|
|
|
| Gigantol isomer-1 |
|
|
|
|
|
|
99.82% |
| GlcCer (d18:1/18:0) |
|
|
|
|
|
|
99.93% |
| GNF-1331 |
|
|
|
|
|
|
99.84% |
| GNF-6231 |
|
|
|
|
|
|
99.63% |
| GSK-3β inhibitor 8 |
|
|
|
|
|
|
98.16% |
| GSK3178022 |
|
|
|
|
|
|
|
| Halofenate |
|
|
|
|
|
|
|
| hCA/Wnt/β-catenin-IN-1 |
|
|
|
|
|
|
99.96% |
| Hematein |
|
|
|
|
|
|
59.09% |
| HIT211504993 |
|
|
|
|
|
|
|
| HLY78 |
|
|
|
|
|
|
98.44% |
| hsBCL9CT-24 |
|
|
|
|
|
|
|
| iCRT 14 |
|
|
|
|
|
|
99.72% |
| iCRT-5 |
|
|
|
|
|
|
99.1% |
| iCRT3 |
|
|
|
|
|
|
98.05% |
| IM-12 |
|
|
|
|
|
|
99.30% |
| Ipafricept |
|
|
|
|
|
|
99.80% |
| Ipivivint |
|
|
|
|
|
|
99.95% |
| IQ 1 |
|
|
|
|
|
|
99.13% |
| IWP-12 |
|
|
|
|
|
|
99.53% |
| IWP-12 (Standard) |
|
|
|
|
|
|
|
| IWP-2 |
|
|
|
|
|
|
99.93% |
| IWP-2 |
|
|
|
|
|
|
|
| IWP-2-V2 |
|
|
|
|
|
|
98.39% |
| IWP-3 |
|
|
|
|
|
|
99.27% |
| IWP-4 |
|
|
|
|
|
|
|
| IWP-4 |
|
|
|
|
|
|
99.81% |
| IWP-O1 |
|
|
|
|
|
|
99.81% |
| IWR-1 |
|
|
|
|
|
|
|
| IWR-1 |
|
|
|
|
|
|
99.60% |
| Jatrophone |
|
|
|
|
|
|
|
| JNK3/Wnt/β-catenin modulator-1 |
|
|
|
|
|
|
|
| JW67 |
|
|
|
|
|
|
98.15% |
| JW74 |
|
|
|
|
|
|
99.05% |
| KP-6 |
|
|
|
|
|
|
|
| KWZY-11 |
|
|
|
|
|
|
|
| KY-02327 |
|
|
|
|
|
|
|
| KY-02327 acetate |
|
|
|
|
|
|
99.24% |
| KY-05009 |
|
|
|
|
|
|
99.88% |
| KY02111 |
|
|
|
|
|
|
99.23% |
| KY1022 |
|
|
|
|
|
|
|
| KY1220 |
|
|
|
|
|
|
98.0% |
| KY19334 |
|
|
|
|
|
|
|
| KY19382 |
|
|
|
|
|
|
98.0% |
| KYA1797K |
|
|
|
|
|
|
98.0% |
| γ-Glutamylvaline |
|
|
|
|
|
|
99.94% |
| L-Quebrachitol |
|
|
|
|
|
|
99.51% |
| Laduviglusib |
|
|
|
|
|
|
99.46% |
| Laduviglusib |
|
|
|
|
|
|
|
| Laduviglusib dihydrochloride |
|
|
|
|
|
|
|
| Laduviglusib monohydrochloride |
|
|
|
|
|
|
99.93% |
| Laduviglusib trihydrochloride |
|
|
|
|
|
|
99.11% |
| Laduviglusib-d4 |
|
|
|
|
|
|
|
| LBM22 |
|
|
|
|
|
|
|
| Longdaysin |
|
|
|
|
|
|
99.83% |
| LP-922056 |
|
|
|
|
|
|
99.63% |
| LP-935001 |
|
|
|
|
|
|
|
| M435-1279 |
|
|
|
|
|
|
98.28% |
| MDGCEL |
|
|
|
|
|
|
|
| ME-143 |
|
|
|
|
|
|
99.01% |
| Methyl vanillate |
|
|
|
|
|
|
99.88% |
| Methyl vanillate-d3 |
|
|
|
|
|
|
|
| Miclxin |
|
|
|
|
|
|
98.12% |
| ML243 |
|
|
|
|
|
|
|
| MSAB |
|
|
|
|
|
|
99.77% |
| Murrayafoline A |
|
|
|
|
|
|
99.73% |
| N-Acetylgalactosaminyltransferase 1 |
|
|
|
|
|
|
|
| NCB-0846 |
|
|
|
|
|
|
99.61% |
| NCB-0970 |
|
|
|
|
|
|
98.81% |
| Nesuparib |
|
|
|
|
|
|
99.54% |
| Nesuparib hydrochloride |
|
|
|
|
|
|
|
| Neurodazine |
|
|
|
|
|
|
99.0% |
| NKP608 |
|
|
|
|
|
|
99.88% |
| NLS-StAx-h |
|
|
|
|
|
|
|
| NLS-StAx-h TFA |
|
|
|
|
|
|
98.87% |
| Nodosin |
|
|
|
|
|
|
98.61% |
| Notum-IN-1 |
|
|
|
|
|
|
|
| Notum-IN-2 |
|
|
|
|
|
|
|
| NSC260594 |
|
|
|
|
|
|
97.50% |
| NSC668036 |
|
|
|
|
|
|
99.9% |
| OM-153 |
|
|
|
|
|
|
99.30% |
| OSU-03013 |
|
|
|
|
|
|
|
| p53 DUBTAC modulator-1 |
|
|
|
|
|
|
|
| Paeonoside |
|
|
|
|
|
|
99.59% |
| Pamidronic acid sodium |
|
|
|
|
|
|
|
| PARP1/2/TNKS1/2-IN-1 |
|
|
|
|
|
|
98.66% |
| PAWI-2 |
|
|
|
|
|
|
99.29% |
| PC8 |
|
|
|
|
|
|
|
| PDE5-IN-3 |
|
|
|
|
|
|
|
| Pen-N3 |
|
|
|
|
|
|
98.38% |
| PF-04840082 |
|
|
|
|
|
|
|
| PI3Kα-IN-16 |
|
|
|
|
|
|
|
| Pin1 modulator 1 |
|
|
|
|
|
|
96.26% |
| Pinobanksin 3-acetate |
|
|
|
|
|
|
99.93% |
| PM54-1 |
|
|
|
|
|
|
|
| PMED-1 |
|
|
|
|
|
|
|
| PNU-74654 |
|
|
|
|
|
|
99.86% |
| Porcn-IN-2 |
|
|
|
|
|
|
|
| PROTAC KDM3 degrader-1 |
|
|
|
|
|
|
99.07% |
| PTD-DBM |
|
|
|
|
|
|
96.12% |
| PTK7/β-catenin-IN-2 |
|
|
|
|
|
|
96.96% |
| PTK7/β-catenin-IN-6 |
|
|
|
|
|
|
|
| QPH-FR |
|
|
|
|
|
|
99.54% |
| QS11 |
|
|
|
|
|
|
99.10% |
| RA-V |
|
|
|
|
|
|
99.85% |
| Remigromig |
|
|
|
|
|
|
|
| Ricinine |
|
|
|
|
|
|
99.81% |
| Sempervirine nitrate |
|
|
|
|
|
|
|
| SEN461 |
|
|
|
|
|
|
|
| SGC-AAK1-1 |
|
|
|
|
|
|
98.47% |
| SGC-CK1γ-1 |
|
|
|
|
|
|
|
| Shizukaol D |
|
|
|
|
|
|
|
| SJ-300 |
|
|
|
|
|
|
|
| SJ26 |
|
|
|
|
|
|
98.65% |
| SKI II |
|
|
|
|
|
|
99.25% |
| SKL2001 |
|
|
|
|
|
|
99.66% |
| SKL2001 (GMP) |
|
|
|
|
|
|
|
| SLD1121 |
|
|
|
|
|
|
|
| SNX3-IN-1 |
|
|
|
|
|
|
|
| SRI 37892 |
|
|
|
|
|
|
99.28% |
| SSTC3 |
|
|
|
|
|
|
99.37% |
| TC-E 5001 |
|
|
|
|
|
|
|
| Teplinovivint |
|
|
|
|
|
|
98.01% |
| TFAP4/Wnt/β-catenin-IN-1 |
|
|
|
|
|
|
95.39% |
| TFMB-(S)-2-HG |
|
|
|
|
|
|
99.79% |
| TK-129 |
|
|
|
|
|
|
≥98.0% |
| TNIK-IN-10 |
|
|
|
|
|
|
|
| TNIK-IN-5 |
|
|
|
|
|
|
99.75% |
| TNIK-IN-8 |
|
|
|
|
|
|
99.58% |
| TNKS-IN-1 |
|
|
|
|
|
|
99.55% |
| TNKS-IN-2 |
|
|
|
|
|
|
|
| TWS119 |
|
|
|
|
|
|
99.89% |
| TWS119 TFA |
|
|
|
|
|
|
|
| UAB116 |
|
|
|
|
|
|
|
| UM206_C |
|
|
|
|
|
|
|
| UM206_L |
|
|
|
|
|
|
|
| UU-T02 |
|
|
|
|
|
|
99.94% |
| Vitisin A |
|
|
|
|
|
|
96% |
| W2A-28 |
|
|
|
|
|
|
|
| WAY 316606 |
|
|
|
|
|
|
99.24% |
| WAY-262611 |
|
|
|
|
|
|
99.96% |
| WAY-362692 |
|
|
|
|
|
|
99.91% |
| WHN-88 |
|
|
|
|
|
|
|
| WIC1 |
|
|
|
|
|
|
99.94% |
| WIKI4 |
|
|
|
|
|
|
99.61% |
| WIKI4 |
|
|
|
|
|
|
|
| Windorphen |
|
|
|
|
|
|
99.75% |
| Withanolide B |
|
|
|
|
|
|
98.52% |
| Wnt pathway activator 2 |
|
|
|
|
|
|
99.38% |
| Wnt pathway inhibitor 3 |
|
|
|
|
|
|
98.96% |
| Wnt pathway inhibitor 4 |
|
|
|
|
|
|
95.0% |
| Wnt pathway inhibitor 5 |
|
|
|
|
|
|
|
| Wnt-C59 |
|
|
|
|
|
|
|
| Wnt-C59 |
|
|
|
|
|
|
99.88% |
| Wnt/β-catenin activator 1 |
|
|
|
|
|
|
|
| Wnt/β-catenin agonist 1 |
|
|
|
|
|
|
99.72% |
| Wnt/β-catenin agonist 2 |
|
|
|
|
|
|
99.70% |
| Wnt/β-catenin agonist 3 |
|
|
|
|
|
|
99.87% |
| Wnt/β-catenin agonist 3 hydrochloride |
|
|
|
|
|
|
99.92% |
| Wnt/β-catenin agonist 4 |
|
|
|
|
|
|
99.68% |
| Wnt/β-catenin-IN-1 |
|
|
|
|
|
|
|
| Wnt/β-catenin-IN-2 |
|
|
|
|
|
|
99.46% |
| Wnt/β-catenin-IN-3 |
|
|
|
|
|
|
|
| Wnt/β-catenin-IN-4 |
|
|
|
|
|
|
|
| Wnt/β-catenin-IN-5 |
|
|
|
|
|
|
|
| Wnt/β-catenin-IN-6 |
|
|
|
|
|
|
98.34% |
| Wnt/β-catenin-IN-7 |
|
|
|
|
|
|
|
| WNT3Ap |
|
|
|
|
|
|
|
| WNT7A-IN-1 |
|
|
|
|
|
|
99.66% |
| WNT7A-IN-1 sodium |
|
|
|
|
|
|
95.74% |
| WNTinib |
|
|
|
|
|
|
99.95% |
| WZU-13 |
|
|
|
|
|
|
|
| XD23 |
|
|
|
|
|
|
|
| XRF-1021 |
|
|
|
|
|
|
|
| xStAx-VHLL |
|
|
|
|
|
|
99.95% |
| xStAx-VHLL TFA |
|
|
|
|
|
|
99.95% |
| Y-99 |
|
|
|
|
|
|
|
| YB-0158 |
|
|
|
|
|
|
99.49% |
| YW1128 |
|
|
|
|
|
|
99.38% |
| YW2036 |
|
|
|
|
|
|
99.48% |
| Zamaporvint |
|
|
|
|
|
|
99.76% |
| ZY-444 |
|
|
|
|
|
|
99.51% |
| β-catenin inhibitory peptoid |
|
|
|
|
|
|
|
| β-catenin modulator IIa-661 |
|
|
|
|
|
|
99.58% |
| β-Catenin modulator-9 |
|
|
|
|
|
|
99.22% |
| β-catenin-IN-10 |
|
|
|
|
|
|
|
| β-catenin-IN-3 |
|
|
|
|
|
|
95.64% |
| β-catenin-IN-37 |
|
|
|
|
|
|
99.13% |
| β-catenin-IN-7 |
|
|
|
|
|
|
|
| β-catenin-IN-8 |
|
|
|
|
|
|
|
| Vantictumab |
|
|
|
|
|
|
99.00% |
| Sodium acetate trihydrate, 99.5% |
|
|
|
|
|
|
99.99% |
| Hexane-2,5-dione |
|
|
|
|
|
|
99.96% |
| Paeonolide |
|
|
|
|
|
|
99.89% |
| Dinactin |
|
|
|
|
|
|
|
| Ethacrynic acid |
|
|
|
|
|
|
99.90% |
| Perfluoroundecanoic acid-13C7 |
|
|
|
|
|
|
|
| Perfluoroundecanoic acid |
|
|
|
|
|
|
99.85% |
| Hexachlorophene |
|
|
|
|
|
|
99.15% |
| Nimbolide |
|
|
|
|
|
|
99.79% |
| Elaidic acid |
|
|
|
|
|
|
99.81% |
| Ajuga Turkestanica Extract |
|
|
|
|
|
|
|
| Nigericin sodium salt |
|
|
|
|
|
|
99.60% |
| Nigericin |
|
|
|
|
|
|
99.64% |
| Pamidronic acid |
|
|
|
|
|
|
99.05% |
| Pamidronate disodium |
|
|
|
|
|
|
98.0% |
| Pamidronate disodium pentahydrate |
|
|
|
|
|
|
98.0% |
| Combretastatin A-1 |
|
|
|
|
|
|
97.03% |
| Pyrvinium pamoate |
|
|
|
|
|
|
99.75% |
| Neohesperidin |
|
|
|
|
|
|
98.67% |
| Prinaberel |
|
|
|
|
|
|
98.05% |
| Tizanidine-d4 |
|
|
|
|
|
|
99.93% |
| Tizanidine |
|
|
|
|
|
|
99.58% |
| Myricetin 3-O-galactoside |
|
|
|
|
|
|
99.27% |
| Echinacoside |
|
|
|
|
|
|
99.71% |
| Platycodin D |
|
|
|
|
|
|
99.34% |
| Flurbiprofen axetil |
|
|
|
|
|
|
99.34% |
| Wogonin |
|
|
|
|
|
|
99.54% |
| Herpetin |
|
|
|
|
|
|
|
| Zilovertamab |
|
|
|
|
|
|
98.21% |
| Rosmantuzumab |
|
|
|
|
|
|
99.29% |
| Prodigiosin |
|
|
|
|
|
|
99.84% |
| Specnuezhenide |
|
|
|
|
|
|
99.52% |
| Chrysosplenetin |
|
|
|
|
|
|
99.84% |
| Tizanidine hydrochloride |
|
|
|
|
|
|
99.93% |
| Tizanidine-d4 hydrochloride |
|
|
|
|
|
|
|
| Prodigiosin hydrochloride |
|
|
|
|
|
|
98.05% |
| Salinomycin |
|
|
|
|
|
|
99.74% |
| Salinomycin sodium salt |
|
|
|
|
|
|
99.81% |
| Dendrophenol |
|
|
|
|
|
|
99.93% |
| Heparan Sulfate |
|
|
|
|
|
|
|
| Chikusetsusaponin IVa methyl ester |
|
|
|
|
|
|
|
| Raddeanin A |
|
|
|
|
|
|
98.68% |
| Mirodenafil |
|
|
|
|
|
|
99.88% |
| Mirodenafil-d7 |
|
|
|
|
|
|
|
| Mirodenafil dihydrochloride |
|
|
|
|
|
|
99.11% |
| Viridicatol |
|
|
|
|
|
|
99.93% |
| Rohitukine |
|
|
|
|
|
|
|
| Nystose |
|
|
|
|
|
|
99.98% |
| Orcinol glucoside |
|
|
|
|
|
|
98.92% |
| Atranorin |
|
|
|
|
|
|
99.68% |
| Monensin |
|
|
|
|
|
|
98.07% |
| Monensin sodium |
|
|
|
|
|
|
98.0% |
| Jervine hydriodide |
|
|
|
|
|
|
|
| Spiperone |
|
|
|
|
|
|
99.00% |
| Cardamonin |
|
|
|
|
|
|
99.80% |
| Fluocinolone acetonide-13C3 |
|
|
|
|
|
|
|
| Fluocinolone (Acetonide) |
|
|
|
|
|
|
99.68% |
| Ginkgetin |
|
|
|
|
|
|
99.87% |
| N-(3-Methoxybenzyl)-(9Z,12Z,15Z)-octadecatrienamide |
|
|
|
|
|
|
99.48% |
| Arjunolic acid |
|
|
|
|
|
|
98.17% |
| Triptonide |
|
|
|
|
|
|
99.75% |
| Wilforine |
|
|
|
|
|
|
99.47% |